Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Impact of Comorbidities on Prognosis of Elderly Patients with Acute Myeloid Leukemia Who Receive Hypomethylating Agents

Blood (2021) 138 (Supplement 1): 3373.

https://doi.org/10.1182/blood-2021-149459

Published: 2021

Journal Articles

AML-CM Score Predicts Prognosis in Hemato-Geriatric Patients with New-Onset Acute Myeloid Leukemia (AML) Who Receive Hypomethylating Agents (HMA)

Giovanni Marconi, Roberta di Nicola, Chiara Sartor, MD, Mariachiara Abbenante, MD, Jacopo Nanni, MD, Gianluca Cristiano, MD, Sarah Parisi, MD PhD, Carmen Baldazzi, PhD, Maria Chiara Fontana, PhD, Lorenza Bandini, Emanuela Ottaviani, Nicoletta Testoni, Giovanni Martinelli, MD, Michele Baccarani, MD, Cristina Papayannidis, Stefania Paolini, MD PhD, Michele Cavo, Antonio Curti, MD PhD

Blood (2019) 134 (Supplement_1): 2617.

https://doi.org/10.1182/blood-2019-130630

Published: 2019

Journal Articles

Biology of Acute Myeloid Leukemia (AML) with Monosomy of Chromosome 7 or Loss of 7q. a Study on 487 Patients Analyzed By Gene Expression Profile (GEP), Single Nucleotide Polymorphism (SNP) Arrays and Metabolomics

Blood (2018) 132 (Supplement 1): 2748.

https://doi.org/10.1182/blood-2018-99-118183

Published: 2018

Journal Articles

Adult "Triple Negative" ACUTE Lymphoblastic Leukemia Genome Wide Characterization

Blood (2017) 130 (Supplement 1): 2720.

https://doi.org/10.1182/blood.V130.Suppl_1.2720.2720

Published: 2017

Journal Articles

A Three-Genes Signature of Anti-Apoptotic Genes Showed Different Mechanisms in Preventing Apoptosis in Acute Myeloid Leukemia Cells and Could Provide an Useful Model to Establish the Proper BH3-Mimetich Drug or Combination

Jacopo Nanni, MD, Giorgia Simonetti, PhD, Giovanni Marconi, MD, Maria Chiara Fontana, MSc, Samantha Bruno, MSc, Cristina Papayannidis, MD, Antonella Padella, Mariachiara Abbenante, MD, Silvia lo Monaco, Elena Tenti, PhD, Chiara Sartor, Sarah Parisi, MD PhD, Giovanni Martinelli, MD

Blood (2017) 130 (Supplement 1): 4969.

https://doi.org/10.1182/blood.V130.Suppl_1.4969.4969

Published: 2017

Journal Articles

MHC-I Antigen Presentation Role in Immune Escape of Acute Myeloid Leukemia with High Burden of Genomic Aberration

Giovanni Marconi, MD, Maria Chiara Fontana, MSc, Eugenio Fonzi, PhD, Cristina Papayannidis, MD, Mariachiara Abbenante, MD, Emanuela Ottaviani, Nicoletta Testoni, BSc, Giorgia Simonetti, PhD, Antonella Padella, Chiara Sartor, Carmen Baldazzi, Jacopo Nanni, MD, Luca Bertamini, MD, Andrea Ghelli Luserna Di Rora, Valentina Robustelli, Martina Pazzaglia, Elena Tenti, PhD, Sarah Parisi, MD PhD, Giovanni Martinelli, MD

Blood (2017) 130 (Supplement 1): 3958.

https://doi.org/10.1182/blood.V130.Suppl_1.3958.3958

Published: 2017

Journal Articles

SIRPB1 Is a Strong Predictor Biomarker of Response to 5-Azacitidine Therapy in MDS and AML Patients

Blood (2014) 124 (21): 1030.

https://doi.org/10.1182/blood.V124.21.1030.1030

Published: 2014

Journal Articles

PKC412 (Midostaurin) Is Safe and Highly Effective in Systemic Mastocytosis Patients: The Bologna Experience

Cristina Papayannidis, Mariachiara Abbenante, Sarah Parisi, Stefania Paolini, Ilaria Iacobucci, Federica Frabetti, Emanuela Ottaviani, Anna Ferrari, Viviana Guadagnuolo, Chiara Sartor, Simona Soverini, Caterina De Benedittis, Carmen Baldazzi, Nicoletta Testoni, Michele Baccarani, Giovanni Martinelli

Blood (2012) 120 (21): 1749.

https://doi.org/10.1182/blood.V120.21.1749.1749

Published: 2012

Journal Articles

Loss of Heterozygosity At the C Wild-Type Allele of rs1042522 in the TP53 Gene Frequently Occurs During Progression of Adult BCR-ABL1 Positive Acute Lymphoblastic Leukemia (ALL).

Blood (2012) 120 (21): 2497.

https://doi.org/10.1182/blood.V120.21.2497.2497

Published: 2012

Journal Articles

Nelarabine Is Safe and Effective In Adult Relapsed or Refractory T Cell Acute Lymphoblastic Leukemia (T-ALL) and Lymphoblastic Lymphoma (T-LBL): The Bologna Experience

Cristina Papayannidis, Ilaria Iacobucci, PhD, Mariachiara Abbenante, Annalisa Lonetti, Viviana Guadagnuolo, Anna Ferrari, Emanuela Ottaviani, Nicoletta Testoni, Carmen Baldazzi, Antonio Curti, MD, Sarah Parisi, Cristina Clissa, MD, Michele Baccarani, MD, Giovanni Martinelli

Blood (2011) 118 (21): 4250.

https://doi.org/10.1182/blood.V118.21.4250.4250

Published: 2011

Journal Articles

Pediatric-Like Intensified Therapy In Adult Acute Lymphoblastic Leukemia: A Single Centre Experience

Sarah Parisi, Stefania Paolini, Ilaria Iacobucci, PhD, Cristina Papayannidis, Mariachiara Abbenante, Antonio Curti, MD, Emanuela Ottaviani, Nicoletta Testoni, Michele Baccarani, MD, Giovanni Martinelli, MD, PhD

Blood (2011) 118 (21): 4261.

https://doi.org/10.1182/blood.V118.21.4261.4261

Published: 2011

Journal Articles

Identification of A Pharmacogenomic Profile Associated with High Sensitivity and Low Toxicity to a Combination of Gemtuzumab Ozogamicin Plus Fludarabine, Cytarabine, Idarubicin Regimen In CD33-Positive Acute Myeloid Leukemia (AML) Patients

Blood (2010) 116 (21): 967.

https://doi.org/10.1182/blood.V116.21.967.967

Published: 2010

Journal Articles

Use of a High Sensitive Nanofluidic Array for the Detection of Rare Copies of BCR-ABL1 Transcript In Patients with Philadelphia-Positive Acute Lymphoblastic Leukemia (ALL).

Ilaria Iacobucci, Annalisa Lonetti, Anna Ferrari, Cristina Papayannidis, Simona Soverini, Stefania Paolini, Mariachiara Abbenante, Viviana Guadagnuolo, Sarah Parisi, Leonardo Potenza, Mario Luppi, Federica Cattina, Domenico Russo, Fabrizio Pane, MD, Michele Baccarani, Giovanni Martinelli

Blood (2010) 116 (21): 1677.

https://doi.org/10.1182/blood.V116.21.1677.1677

Published: 2010

Journal Articles

Susceptibility to Philadelphia-Positive acute Lymphoblastic Leukemia (ALL) Is Associated with a Germline Polymorphism In the ANRIL ( CDKN2BAS ) Locus.

Ilaria Iacobucci, Marco Sazzini, Anna Ferrari, Annalisa Lonetti, Alessio Boattini, Cristina Papayannidis, Paolo Garagnani, Mariachiara Abbenante, Vilma Mantovani, Elena Marasco, Emanuela Ottaviani, Stefania Paolini, Domenico Girelli, Marco Vignetti, Fabrizio Pane, MD, Simona Soverini, Michele Baccarani, Giovanni Martinelli

Blood (2010) 116 (21): 1670.

https://doi.org/10.1182/blood.V116.21.1670.1670

Published: 2010

Journal Articles

Evaluation of the GeneXpert Assay for the Monitoring of BCR-ABL Transcript Levels In Chronic Myeloid Leukemia (CML) Patients: Preliminary Results of a Comparison with the Manual and Traditional Manual TaqMan RQ-PCR Assay

Marco Suriano, Giovanni Martinelli, Angela Poerio, Marilina Amabile, Gianantonio Rosti, Fausto Castagnetti, Ilaria Iacobucci, Simona Soverini, Annalisa Lonetti, Cristina Papayannidis, Mariachiara Abbenante, Sarah Parisi, Francesca Palandri, Michele Baccarani, MD

Blood (2010) 116 (21): 4831.

https://doi.org/10.1182/blood.V116.21.4831.4831

Published: 2010

Journal Articles

The Inactivation of the Tumor Suppressor Genes CDKN2A/ARF by Genomic Deletions Frequently Occurs and Worsens Prognosis In Adult BCR-ABL1 Positive Acute Lymphoblastic Leukemia (ALL) Patients

Ilaria Iacobucci, Anna Ferrari, Annalisa Lonetti, Cristina Papayannidis, Viviana Guadagnuolo, Emanuela Ottaviani, Mariachiara Abbenante, Federica Cattina, Antonella Vitale, Stefania Paolini, Simona Soverini, Sarah Parisi, Francesca Paoloni, BS, Fausto Castagnetti, Marco Vignetti, Robin Foà, Michele Baccarani, Giovanni Martinelli

Blood (2010) 116 (21): 3136.

https://doi.org/10.1182/blood.V116.21.3136.3136

Published: 2010

Journal Articles

Efficacy and Feasibility of Nelarabine Savage Therapy In Adult Relapsed or Refractory T Cell Acute Lymphoblastic Leukemia (T-ALL) and Lymphoblastic Lymphoma (T-LBL) Strongly Indicates the Introduction of a Nelarabine-Based First Line Regimen

Cristina Papayannidis, Ilaria Iacobucci, Mariachiara Abbenante, Stefania Paolini, Sarah Parisi, Annalisa Lonetti, Viviana Guadagnuolo, Anna Ferrari, Emanuela Ottaviani, Nicoletta Testoni, Antonio Curti, Cristina Clissa, MD, Michele Baccarani, Giovanni Martinelli, MD

Blood (2010) 116 (21): 4335.

https://doi.org/10.1182/blood.V116.21.4335.4335

Published: 2010

NARROW

Impact of Comorbidities on Prognosis of Elderly Patients with Acute Myeloid Leukemia Who Receive Hypomethylating Agents

AML-CM Score Predicts Prognosis in Hemato-Geriatric Patients with New-Onset Acute Myeloid Leukemia (AML) Who Receive Hypomethylating Agents (HMA)

Biology of Acute Myeloid Leukemia (AML) with Monosomy of Chromosome 7 or Loss of 7q. a Study on 487 Patients Analyzed By Gene Expression Profile (GEP), Single Nucleotide Polymorphism (SNP) Arrays and Metabolomics

Adult "Triple Negative" ACUTE Lymphoblastic Leukemia Genome Wide Characterization

A Three-Genes Signature of Anti-Apoptotic Genes Showed Different Mechanisms in Preventing Apoptosis in Acute Myeloid Leukemia Cells and Could Provide an Useful Model to Establish the Proper BH3-Mimetich Drug or Combination

MHC-I Antigen Presentation Role in Immune Escape of Acute Myeloid Leukemia with High Burden of Genomic Aberration

SIRPB1 Is a Strong Predictor Biomarker of Response to 5-Azacitidine Therapy in MDS and AML Patients

PKC412 (Midostaurin) Is Safe and Highly Effective in Systemic Mastocytosis Patients: The Bologna Experience

Loss of Heterozygosity At the C Wild-Type Allele of rs1042522 in the TP53 Gene Frequently Occurs During Progression of Adult BCR-ABL1 Positive Acute Lymphoblastic Leukemia (ALL).

Nelarabine Is Safe and Effective In Adult Relapsed or Refractory T Cell Acute Lymphoblastic Leukemia (T-ALL) and Lymphoblastic Lymphoma (T-LBL): The Bologna Experience

Pediatric-Like Intensified Therapy In Adult Acute Lymphoblastic Leukemia: A Single Centre Experience

Identification of A Pharmacogenomic Profile Associated with High Sensitivity and Low Toxicity to a Combination of Gemtuzumab Ozogamicin Plus Fludarabine, Cytarabine, Idarubicin Regimen In CD33-Positive Acute Myeloid Leukemia (AML) Patients

Use of a High Sensitive Nanofluidic Array for the Detection of Rare Copies of BCR-ABL1 Transcript In Patients with Philadelphia-Positive Acute Lymphoblastic Leukemia (ALL).

Susceptibility to Philadelphia-Positive acute Lymphoblastic Leukemia (ALL) Is Associated with a Germline Polymorphism In the ANRIL ( CDKN2BAS ) Locus.

Evaluation of the GeneXpert Assay for the Monitoring of BCR-ABL Transcript Levels In Chronic Myeloid Leukemia (CML) Patients: Preliminary Results of a Comparison with the Manual and Traditional Manual TaqMan RQ-PCR Assay

The Inactivation of the Tumor Suppressor Genes CDKN2A/ARF by Genomic Deletions Frequently Occurs and Worsens Prognosis In Adult BCR-ABL1 Positive Acute Lymphoblastic Leukemia (ALL) Patients

Efficacy and Feasibility of Nelarabine Savage Therapy In Adult Relapsed or Refractory T Cell Acute Lymphoblastic Leukemia (T-ALL) and Lymphoblastic Lymphoma (T-LBL) Strongly Indicates the Introduction of a Nelarabine-Based First Line Regimen

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only